| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.31 | 0.3 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.33 | 0.07 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.34 | 0.07 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.38 | 5e-08 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.4 | 0.004 |